• Return to Headlines

Exelixis Inc Shares Down 37.4% Since SmarTrend's Sell Call (EXEL)

By Shiri Gupta

SmarTrend identified a Downtrend for Exelixis Inc (NASDAQ:EXEL) on February 28th, 2018 at $26.69. In approximately 7 months, Exelixis Inc has returned 37.42% as of today's recent price of $16.70.

In the past 52 weeks, shares of Exelixis Inc have traded between a low of $7.20 and a high of $32.50 and are now at $16.70, which is 132% above that low price. The 200-day and 50-day moving averages have moved 0.53% lower and 1.13% lower over the past week, respectively.

Exelixis, Inc. is a development-stage biotechnology company dedicated to the discovery and development of small-molecule therapeutics for the treatment of cancer and other serious diseases. The Company is building a portfolio of compounds it believes could become pharmaceutical products. Exelixis has strategic alliances with pharmaceutical and biotechnology companies.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Exelixis Inc.

Log in and add Exelixis Inc (EXEL) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights exelixis inc

Ticker(s): EXEL